• News
  • Business
  • Education
  • Technology
  • Health
  • Travel
Khaleej Mag
  • News
  • Business
  • Education
  • Sports
  • More
    • Health
    • Entrepreneurship
    • Islam
    • Technology
    • Travel
    • Contact Us
  • Facebook

  • Twitter

  • Instagram

  • LinkedIn

  • RSS

News

Scientists Investigate Deadly Bundibugyo Ebola Outbreak in DR Congo as Cases Exceed 11,000

Scientists Investigate Deadly Bundibugyo Ebola Outbreak in DR Congo as Cases Exceed 11,000
Web Reporter
November 21, 2026

Scientists and medical teams are gaining new insights into the rare Bundibugyo strain of Ebola as a devastating outbreak in the Democratic Republic of Congo (DRC) continues to spread, raising concerns about delayed diagnosis, high mortality rates among children and the lack of approved vaccines or treatments.

The outbreak has recorded more than 11,000 cases and over 5,500 deaths, with the virus spreading at twice the pace of the 2014-2016 Ebola epidemic in West Africa, the largest on record.

Researchers are investigating the characteristics of the Bundibugyo virus to better understand its transmission and identify effective ways to contain it. However, experts have warned that the humanitarian crisis in eastern Congo, where the outbreak is concentrated, is complicating the collection of reliable data.

“There are so many different factors to compare across outbreaks, even within outbreaks, it is really hard,” said Daniel Bausch, a member of the World Health Organization’s Ebola emergency committee and visiting professor at the Geneva Graduate Institute.

WHO Ebola incident manager Catherine Smallwood said teams were gathering evidence to improve the response to the outbreak.

” Soon we’ll be able to make some bold statements about what’s the same, what’s different, and what we need to adjust,” she said.

Bleeding less common among patients

One of the main findings concerns the symptoms associated with the Bundibugyo strain, particularly among children.

Ebola typically causes fever, vomiting and diarrhoea, with severe cases sometimes involving internal and external bleeding. However, bleeding has been reported in only around 5 to 10 per cent of confirmed cases in the current outbreak, according to Yap Boum, Africa Centres for Disease Control and Prevention deputy Ebola incident manager.

The symptom is less common than in outbreaks involving the Zaire strain, potentially making Bundibugyo more difficult to distinguish from other illnesses, including malaria.

The difficulty in diagnosing the virus, combined with early testing challenges, may have contributed to the delayed identification of the outbreak. Tests designed for other Ebola strains do not detect Bundibugyo.

Around 70 per cent of patients are still dying in their communities rather than healthcare facilities, complicating efforts to monitor transmission. The WHO and Africa CDC believe the virus may have been spreading for months before the outbreak was officially declared in May.

Children face higher mortality

Children under five have been particularly affected, with 1,207 confirmed cases and 844 deaths, according to figures from the Congolese health ministry and WHO. The fatality rate among young children is approximately 70 per cent, compared with around 50 per cent among adults.

WHO officials said gastrointestinal symptoms are more common in young children than fever, making early diagnosis and treatment more difficult.

Although the mortality rate is higher than in previous Bundibugyo outbreaks, it remains below the levels associated with some other Ebola strains, including Zaire, which can have fatality rates of up to 80 per cent without treatment.

Vaccines and treatments under investigation

Researchers are also studying the long-term effects of infection and the prevalence of milder cases. Around 700 survivors have enrolled in research and support programmes, according to the WHO.

Genomic sequencing has found differences between Bundibugyo and more common Ebola strains, but researchers have not identified evidence that the virus is rapidly evolving or becoming more transmissible.

A trial is examining whether Merck’s Ervebo vaccine, developed against the Zaire strain, could provide protection against Bundibugyo. Vaccines specifically designed for the strain are also expected to enter trials, while antiviral drugs from Gilead Sciences and Mapp Biopharmaceutical are being tested in Congo.

Experts say isolating patients and other established containment measures have helped control transmission in some early hotspots.

Yap Boum said evidence that vaccines or treatments could offer protection would significantly change the response to the outbreak, which currently has no licensed medical interventions specifically targeting Bundibugyo.

Comments

Related Itemsnews
Click to add a comment

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

You must be logged in to post a comment.

News
November 21, 2026
Web Reporter

Related Itemsnews

More in News

Trump Says Packed Asia Schedule Prevented Meeting with North Korea’s Kim Jong Un

Web ReporterNovember 20, 2026
Read More

China Says It Has No Information on Possible Trump-Kim Meeting During Asia Trip

Web ReporterNovember 17, 2026
Read More

Trump Administration Seeks $50 Billion to Modernise US Air Traffic Control System

Web ReporterNovember 16, 2026
Read More

SpaceX Starship Completes First Midair Return Catch Despite Booster Failure

Web ReporterNovember 15, 2026
Read More

Punjab Expands Crackdown on Crop Burning as Smog Returns to Lahore

Web ReporterNovember 14, 2026
Read More

Microsoft Confirms Full Recovery After Global Outage Disrupts Services for More Than 24 Hours

Web ReporterNovember 14, 2026
Read More

Congo Ebola Outbreak Spreads as MSF Warns of Missed Cases and Hospital Infections

Web ReporterNovember 13, 2026
Read More

Irish Alumina Shipments to Russia Face Scrutiny Over Possible Links to Moscow’s War Effort

Web ReporterNovember 12, 2026
Read More

Imran Khan Taken to Islamabad Hospital for Overnight Eye Treatment

Web ReporterNovember 11, 2026
Read More
Scroll for more
Tap
  • Recent
  • Popular
  • Tags

Khaleej Mag
Khaleej Mag is your premier source for insightful stories, vibrant culture, and dynamic perspectives from across the Arabian Gulf region and the rest of the world. Explore the essence of Gulf life with captivating articles, stunning visuals, and exclusive features. Stay informed, inspired, and connected with Khaleej Mag. Contact us at editor@khaleejmag.com.

Follow Us

  • X
  • Facebook
  • LinkedIn
  • Instagram

Copyright © 2018 Khaleej Mag

Trump Says Packed Asia Schedule Prevented Meeting with North Korea’s Kim Jong Un